InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+12.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Browse the full record of transactions filed by Vizirgianakis Stavros G., 董事长兼首席执行官. Officer active across 4 companies, notably MISONIX INC. Aggregated, 11 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €1.1m. Activity tracked since 16 June 2022. The latest transaction was filed on 15 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Vizirgianakis Stavros G.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
323,275 股0Common StockSEC:0001559834-26-000001:0
450,000 股Restricted Stock UnitsSEC:0001493152-26-028771:0
553,797 股0Common StockSEC:0001559834-25-000006:0
243,243 股0Common StockSEC:0001235802-24-000071:0
217,770 股0Common StockSEC:0001235802-23-000094:0
144,639 股0Common Stock, $0.000001 par valueSEC:0001235802-22-000122:0
2,264,861 股@ US$0.48100.0% 占其流量Common Stock, $0.000001 par valueSEC:0001235802-22-000113:0
标准退出：2023年1月5日 (T+90)
70,776 股0Common Stock, $0.000001 par valueSEC:0001235802-22-000107:0
965 股0Class A common stockSEC:0000899243-22-023647:0
2,780,923 股Class A Common StockSEC:0000899243-22-015851:0
2,136,478 股Common StockSEC:0001493152-21-030853:0
11 条申报中的 11 条
About Vizirgianakis Stavros G.
Vizirgianakis Stavros G. is President and CEO. He is associated with Xtant Medical Holdings, Inc., Bioventus Inc., Apyx Medical Corp and MISONIX INC. The 10 filings on record range from 2021-12-08 to 2026-06-15, and the buy transactions observed in this recent sample total EUR 1110561, with attribution as the dominant transaction nature.
